 |
АвтоАвтоматизацияАрхитектураАстрономияАудитБиологияБухгалтерияВоенное делоГенетикаГеографияГеологияГосударствоДомДругоеЖурналистика и СМИИзобретательствоИностранные языкиИнформатикаИскусствоИсторияКомпьютерыКулинарияКультураЛексикологияЛитератураЛогикаМаркетингМатематикаМашиностроениеМедицинаМенеджментМеталлы и СваркаМеханикаМузыкаНаселениеОбразованиеОхрана безопасности жизниОхрана ТрудаПедагогикаПолитикаПравоПриборостроениеПрограммированиеПроизводствоПромышленностьПсихологияРадиоРегилияСвязьСоциологияСпортСтандартизацияСтроительствоТехнологииТорговляТуризмФизикаФизиологияФилософияФинансыХимияХозяйствоЦеннообразованиеЧерчениеЭкологияЭконометрикаЭкономикаЭлектроникаЮриспунденкция
Central Nervous System Disorder
Zoloft 2.1
Neurontin 1.3
Viagra 1.3
Celebrex 1.2
Source: Pfizer 2000 Annual Report.
25
This document is authorized for use only in MMIM S2 SEP12 - Marketing by IE Business School at IE Business School from September 2012 to December 2013.
505-038 -26-
Exhibit 13 Viagra's Worldwide Sales by Quarter (1998–2002, $ millions)
| Country | 3/98 | 4/98 | 1/99 | 2/99 | 3/99 | 4/99 | 1/00 | 2/00 | 3/00 | 4/00 | 1/01 | 2/01 | 3/01 | 4/01 | 1/02 | CAGR |
| United States | 157.7 | 144.6 | 147.3 | 164.4 | 156.7 | 175.2 | 183.1 | 193.5 | 201.1 | 202.7 | 216.8 | 214.7 | 221.3 | 246.5 | 238.0 | 16.4% |
| United Kingdom | 0.9 | 3.3 | 4.8 | 6.5 | 9.2 | 10.2 | 10.1 | 10.6 | 11.4 | 12.1 | 12.3 | 13.2 | 14.4 | 15.3 | 14.5 | 26.3 |
| Germany | 0.9 | 11.2 | 9.8 | 10.5 | 12.0 | 11.8 | 10.1 | 10.5 | 11.0 | 11.4 | 11.7 | 11.8 | 11.8 | 12.4 | 11.7 | 3.6 |
| Italy | -- | 5.6 | 4.6 | 5.4 | 6.3 | 7.2 | 6.9 | 7.6 | 7.8 | 8.1 | 9.2 | 9.5 | 9.0 | 9.5 | 9.5 | 20.6 |
| France | -- | 5.9 | 4.3 | 4.3 | 4.3 | 4.3 | 4.1 | 4.7 | 5.0 | 4.9 | 5.4 | 5.6 | 5.4 | 5.5 | 5.9 | 14.8 |
| Spain | -- | 3.1 | 2.2 | 2.6 | 3.0 | 3.1 | 3.1 | 3.5 | 3.6 | 4.0 | 4.4 | 4.7 | 4.4 | 5.0 | 4.8 | 26.6 |
| Russian Fed. | -- | 0.2 | 0.3 | 0.5 | 0.5 | 0.6 | 0.7 | 0.5 | 0.9 | 1.1 | 1.2 | 1..2 | 1.4 | 1.4 | 1.3 | 51.8 |
| Finland | -- | 1.9 | 1.4 | 1.6 | 1.5 | 1.9 | 1.6 | 1.7 | 1.6 | 1.8 | 1.9 | 2.0 | 2.0 | 2.2 | 2.0 | 11.5 |
| Switzerland | 2.1 | 1.7 | 1.4 | 1.5 | 1.5 | 1.6 | 1.4 | 1.5 | 1.5 | 1.6 | 1.7 | 2.0 | 1.9 | 2.1 | 1.9 | 14.7 |
| Netherlands | 0.1 | 1.0 | 1.0 | 1.0 | 1.1 | 1.3 | 1.3 | 1.4 | 1.4 | 1.4 | 1.5 | 1.6 | 1.5 | 1.6 | 1.6 | 15.8 |
| Belgium | -- | 1.1 | 1.1 | 1.2 | 1.3 | 1.5 | 1.3 | 1.4 | 1.3 | 1.4 | 1.5 | 1.6 | 1.6 | 1.7 | 1.6 | 10.7 |
| Norway | -- | 0.4 | 0.9 | 0.8 | 0.9 | 1.1 | 0.9 | 1.0 | 1.0 | 1.1 | 1.1 | 1.2 | 1.2 | 1.4 | 1.3 | 17.4 |
| Austria | -- | 1.1 | 0.9 | 0.9 | 1.0 | 1.1 | 0.9 | 1.0 | 1.0 | 1.1 | 1.2 | 1.2 | 1.2 | 1.3 | 1.3 | 13.2 |
| Greece | -- | -- | 0.1 | 0.5 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.9 | 1.0 | 1.1 | 1.1 | 1.1 | 33.9 |
| Hungary | -- | -- | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | 0.9 | 0.9 | 0.9 | 1.1 | 1.2 | 1.2 | 30.1 |
| Israel | 0.2 | 0.5 | 0.8 | 0.7 | 1.2 | 1.2 | 1.3 | 1.4 | 1.4 | 1.3 | 1.3 | 1.2 | 1.2 | 1.1 | 1.0 | 1.1 |
| Turkey | -- | -- | -- | 0.4 | 0.5 | 1.0 | 1.5 | 2.2 | 2.6 | 3.1 | 2.2 | 2.2 | 2.7 | 1.8 | 1.8 | 58.1 |
| Canada | -- | -- | 1.9 | 5.1 | 4.8 | 6.3 | 6.2 | 7.2 | 7.6 | 8.1 | 7.5 | 8.6 | 9.0 | 9.8 | 9.1 | 27.7 |
| Mexico | 1.8 | 2.2 | 3.1 | 3.3 | 3.8 | 4.8 | 6.6 | 6.5 | 7.2 | 8.2 | 8.9 | 9.6 | 9.2 | 10.8 | 10.8 | 47.8 |
| Brazil | 6.0 | 7.2 | 5.1 | 5.6 | 6.5 | 7.2 | 7.9 | 9.5 | 11.4 | 12.1 | 12.1 | 12.5 | 12.2 | 12.8 | 13.6 | 37.1 |
| Venezuela | 0.5 | 0.9 | 1.0 | 1.1 | 1.3 | 1.5 | 1.6 | 2.0 | 2.1 | 2.7 | 2.6 | 3.1 | 3.1 | 3.7 | 3.5 | 56.1 |
| Central America | 0.1 | 0.1 | 0.4 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.8 | 0.9 | 1.0 | 1.0 | 1.0 | 1.1 | 1.1 | 29.6 |
| Puerto Rico | 0.8 | 1.0 | 1.2 | 1.1 | 1.1 | 1.5 | 1.5 | 1.5 | 1.7 | 2.0 | 1.9 | 1.8 | 2.0 | 2.3 | 0.0 | 24.0 |
| Japan | -- | -- | 11.2 | 10.9 | 10.2 | 10.9 | 9.4 | 11.8 | 12.1 | 13.6 | 10.7 | 12.4 | 12.2 | 14.0 | 11.4 | 9.9 |
| Taiwan | -- | -- | 0.7 | 2.8 | 2.3 | 2.3 | 2.6 | 3.0 | 2.9 | 3.2 | 3.3 | 3.8 | 3.1 | 4.2 | 3.9 | 22.5 |
| Korea | -- | -- | -- | -- | -- | 1.6 | 1.3 | 2.0 | 2.8 | 3.2 | 3.4 | 3.3 | 3.5 | 4.1 | 4.6 | 16.6 |
| Malaysia | -- | -- | -- | 1.0 | 1.2 | 1.2 | 1.1 | 1.2 | 1.3 | 1.2 | 1.3 | 1.3 | 1.2 | 1.3 | 1.2 | 6.5 |
| Australia | 2.0 | 2.4 | 2.2 | 2.5 | 2.7 | 3.0 | 2.9 | 2.9 | 3.1 | 3.2 | 2.8 | 3.4 | 3.7 | 4.0 | 3.7 | 15.5 |
| Saudi Arabia | -- | -- | -- | 1.6 | 2.7 | 3.1 | 3.5 | 3.5 | 4.6 | 4.2 | 5.0 | 5.1 | 5.2 | 5.2 | 5.8 | 39.8 |
| Poland | -- | -- | -- | 0.6 | 0.8 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 1.0 | 1.0 | 1.0 | 1.0 | 19.5 |
| Czech Republic | -- | -- | 0.6 | 0.4 | 0.5 | 0.5 | 0.5 | 0.6 | 0.5 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 | 0.7 | 21.4 |
| New Zealand | -- | 0.4 | 0.4 | 0.6 | 0.7 | 0.6 | 0.9 | 0.7 | 0.8 | 1.6 | 0.9 | 0.9 | 0.6 | 0.7 | 0.7 | 1.8 |
| Hong Kong | -- | -- | 0.4 | 0.4 | 0.5 | 0.5 | 0.6 | 0.5 | 0.6 | 0.5 | 0.8 | 0.4 | 0.7 | 0.6 | 0.6 | 7.2 |
| All Other | 3.0 | 6.5 | 7.0 | 8.1 | 9.1 | 9.9 | 11.2 | 10.1 | 11.0 | 10.8 | 11.9 | 11.7 | 12.2 | 12.2 | 11.5 | 11.5 |
| Total | 176.1 | 202.3 | 216.8 | 249.0 | 251.0 | 280.7 | 288.9 | 308.4 | 325.4 | 335.6 | 350.7 | 356.1 | 363.8 | 399.7 | 383.8 | 18.6 |
Source: Adapted from IMS Health data.
Поиск по сайту: